The Fish Oil Mistake I Made as a Doctor
Most fish oil supplements do not appear to prevent heart attacks. But one purified omega-3 has a very different story.
A Question Worth Asking
What if one of the most common “heart healthy” supplements is mostly giving people reassurance, not protection?
That is the uncomfortable question I had to ask myself about fish oil, which I took daily (even though I hate fish!).
I also walk through this step-by-step here (video):
For years, I took over-the-counter omega-3 capsules because I thought they were protecting my heart. It seemed reasonable. Omega-3s sounded biologically plausible. Fish intake has long been associated with better cardiovascular health. The bottles were everywhere. The marketing was confident. And compared with prescription medications, fish oil felt safe, natural, and harmless.
But medicine has a way of humbling us. A good story is not the same thing as a good trial.
When researchers have tested ordinary over-the-counter fish oil supplements, especially the common EPA plus DHA combinations, the results have generally not shown what many people assume. These supplements have not reliably reduced heart attacks, strokes, or cardiovascular death in broad populations. The American College of Cardiology has summarized this point plainly: routine use of non-prescription fish oil is not recommended for primary or secondary prevention of cardiovascular disease. (American College of Cardiology)
That does not mean omega-3 biology is useless. It means the details matter.
EPA and DHA are not interchangeable. Dose matters. Purity matters. The patient population matters. Whether someone has established cardiovascular disease matters. Whether triglycerides remain elevated despite statin therapy matters. And the distinction between a supplement bottle from a retail shelf and a prescription medication studied in thousands of high-risk patients matters.
The most important example is icosapent ethyl, a purified prescription form of EPA. In the REDUCE-IT trial, high-risk patients taking statins who received icosapent ethyl had fewer major cardiovascular events than those taking placebo. This is the finding behind much of the excitement about prescription EPA. It is not the same as saying that ordinary fish oil capsules prevent heart attacks. It is a much narrower, more clinically specific claim. (American College of Cardiology)
There is also a safety side. Higher-dose omega-3 treatment has been linked to a higher risk of atrial fibrillation, a heart rhythm problem that can increase stroke risk and often requires ongoing medical management. The risk is not enormous in absolute terms, but it is real enough that it should be part of the discussion, especially for people with a history of arrhythmias or those taking blood thinners. (Cedars-Sinai)
So the better question is not, “Is fish oil good or bad?”
The better question is: Which omega-3, at what dose, for which person, and for what outcome?
That is less catchy than the label on a supplement bottle. But it is much closer to how careful medicine works.
A Clinical Pearl People Often Miss
A patient once told me, “I’m already taking fish oil, so I think I’m doing something for my heart.”
That sentence captures a common problem. People often treat supplements as if they are softer versions of prescription medications. But in cardiovascular prevention, that assumption can mislead.
The clinical pearl is this: do not mentally group all omega-3 products together.
Eating fatty fish, taking an over-the-counter EPA/DHA supplement, taking high-dose prescription omega-3 for triglycerides, and taking purified prescription EPA for cardiovascular risk reduction are not the same intervention.
For most generally healthy people, the most defensible “omega-3 strategy” is still food first: eat fish if you can, especially oily fish such as salmon, sardines, or mackerel.
For people at higher cardiovascular risk, especially those with established cardiovascular disease or diabetes plus other risk factors, prescription EPA may be worth discussing with a physician. But that is a medical decision, not a supplement aisle decision.
The subtle mistake is thinking the word “omega-3” tells you enough. It does not.
Three Worthwhile Reads
1. “AstraZeneca’s Blood Pressure Drug Wins U.S. Approval”
This recent story covers the FDA approval of baxdrostat, a new aldosterone-targeting medication for patients with uncontrolled high blood pressure despite existing treatment. I include it because hypertension remains one of the most important drivers of cardiovascular risk, and new approaches to difficult-to-control blood pressure may matter for many patients over time. (Reuters)
2. “US Health Secretary Kennedy Fires Heads of Key Preventive Health Panel”
This is not a supplement story, but it is highly relevant to patients. The U.S. Preventive Services Task Force influences which preventive services are recommended and often covered without cost-sharing. Any disruption to that process deserves public attention because prevention guidelines affect cancer screening, heart disease prevention, and many everyday clinical decisions. (Reuters)
3. “US Cancer Clinics Scramble to Get Experimental Revolution Medicines Pancreatic Cancer Drug”
This article describes early access efforts for an experimental pancreatic cancer drug, daraxonrasib, after promising survival data. It is worth reading because it shows the tension between hope, evidence, access, and urgency in serious illness. For patients and families, these stories are emotionally powerful, but they also require careful interpretation. (Reuters)
One Final Thought
One of the hardest things in health is learning when a simple story has become too simple.
“Fish oil is good for your heart” is simple. It is also incomplete.
The more accurate story is less convenient but more useful: real food is different from supplements, EPA is different from DHA, prescription products are different from retail bottles, and a result in high-risk patients does not automatically apply to everyone.
That kind of nuance can feel frustrating. But it is also where better decisions begin.
Thank you for reading. If you know someone who takes fish oil for heart health, or someone trying to make sense of supplements and cardiovascular prevention, feel free to pass this along. These are exactly the kinds of questions that are easy to oversimplify and worth slowing down to understand.
To your health,
-Dr. Haque
—
This newsletter is for educational and informational purposes only and should not be considered personal medical advice. Always consult your physician or a qualified healthcare professional before making changes to your medications, diet, supplements, exercise, or health routine. Reading this content does not create a physician–patient relationship with Dr. Haque.